Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 25Carcinoma, Non-Small-Cell Lung 6Small Cell Lung Carcinoma 2Pulmonary Disease, Chronic Obstructive 2Pneumonia 2Lung Diseases 2Hemoptysis 2Tuberculosis 1Smoking 1Pulmonary Fibrosis 1Precancerous Conditions 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Lung Diseases, Obstructive 1Lung Diseases, Interstitial 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1Bronchitis 1Bronchiectasis 1

Interventions

pembrolizumab 9Carboplatin 9Docetaxel 8Paclitaxel 6Nivolumab 6Cisplatin 5Gemcitabine 4Albumin-Bound Paclitaxel 4130-nm albumin-bound paclitaxel 4osimertinib 3fludarabine 3aldesleukin 3Radiotherapy 3Pemetrexed 3Erlotinib Hydrochloride 3Cyclophosphamide 3motexafin gadolinium 2figitumumab 2cemiplimab 2brigatinib 2atezolizumab 2alpha-2'-deoxythioguanosine 2Taxes 2Radiosurgery 2Ipilimumab 2Interleukin-2 2Crizotinib 2Bevacizumab 2vistusertib 1vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × Bronchoscopy × Thoracic × Clear all
NCT03881098 2026-06-03

The Lung PCA: A Multi-Dimensional Atlas of Pulmonary Premalignancy

University of Colorado, Denver

Phase NA Active not recruiting
240 enrolled
Thoracic

Carcinoma, Squamous Cell, Lung Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡